23andMe has appointed Kathy Hibbs to be its chief legal and regulatory officer. Previously she served as senior vice president and general counsel for Genomic Health and has also held related posts at Monogram Biosciences and Varian Medical Systems. She is active in several industry groups, including the American Clinical Laboratory Association and the Personalized Medicine Coalition. She holds a JD from the University of California, Hastings School of Law.
CollabRx has appointed Paul Billings to its board of directors. Billings is a board certified internist and clinical geneticist and most recently served as chief medical officer for Life Technologies. He is executive chairman of Melanoma Diagnostics, a director of Trovagene, and a co-founder and past medical director of the Cordblood Registry. He also was a senior vice president for corporate development at Laboratory Corporation of America and a co-founder of Omicia.
He serves on the scientific advisory board of the US Food and Drug Administration, the Genomic Medicine Advisory Committee at the Department of Veteran Affairs, and the National Academy of Sciences Institute of Medicine's Roundtable on Genomics.